1-9 of 9
Ross Baker
Close
Sort by
Journal Articles

Mosunetuzumab Monotherapy Demonstrates Activity and a Manageable Safety Profile in Patients with Relapsed or Refractory Richter's Transformation

Chan Y. Cheah, Sarit Assouline, Ross Baker, Nancy L. Bartlett, Dima El-Sharkawi, Pratyush Giri, Matthew Ku, Stephen J. Schuster, Matthew Matasar, John Radford, Michael C. Wei, Shen Yin, Iris To, Jiangeng Huang, Antonia Kwan, L. Elizabeth Budde
Journal: Blood
Blood (2023) 142 (Supplement 1): 614.
https://doi.org/10.1182/blood-2023-173796
Published: 2023
Journal Articles

Age Regulates Desmopressin Responses in Patients with Low Von Willebrand Factor and Type 1 Von Willebrand Disease in the Lovic and Win Studies

Ferdows Atiq, Robin Blok, Calvin Van Kwawegen, Dearbhla Doherty, Michelle Lavin, Johanna G. Van Der Bom, Niamh O'Connell, Joke De Meris, Kevin Ryan, Saskia Schols, Mary Byrne, Floor Moenen, Karin PM Van Galen, Roger J.S Preston, Karin Fijnvandraat, Ross Baker, Karina Meijer, Paula James, Jorge Di Paola, Jeroen Eikenboom, James S. O'Donnell, Frank W.G. Leebeek
Journal: Blood
Blood (2023) 142 (Supplement 1): 510.
https://doi.org/10.1182/blood-2023-184734
Published: 2023
Journal Articles

The Relationship between Low Von Willebrand Factor, Type 1 Von Willebrand Disease and Ageing - Novel Insights from the Lovic and Win Cohort Studies

Ferdows Atiq, Robin Blok, Calvin Van Kwawegen, Dearbhla Doherty, Michelle Lavin, Johanna G. Van Der Bom, Niamh O'Connell, Joke De Meris, Kevin Ryan, Saskia Schols, Mary Byrne, Floor Moenen, Karin PM Van Galen, Roger J.S Preston, Karin Fijnvandraat, Ross Baker, Karina Meijer, Paula James, Jorge Di Paola, Jeroen Eikenboom, Frank W.G. Leebeek, James S. O'Donnell
Journal: Blood
Blood (2023) 142 (Supplement 1): 509.
https://doi.org/10.1182/blood-2023-181603
Published: 2023
Journal Articles

Phase 1/2a Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of Pxs-5505 in Patients with Primary, Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis

Ross Baker, Jana Baskar, Brett Charlton, Gabriela S. Hobbs, Wolfgang Jarolimek, Sung-Eun Lee, Lucia Masarova, Anne-Marie Watson
Journal: Blood
Blood (2022) 140 (Supplement 1): 3947–3948.
https://doi.org/10.1182/blood-2022-158344
Published: 2022
Journal Articles

Isatuximab Plus Carfilzomib and Dexamethasone in Patients with Early Versus Late Relapsed Multiple Myeloma: Ikema Subgroup Analysis

Thierry Facon, Philippe Moreau, Ross Baker, Ludek Pour, Chang-Ki Min, Xavier Leleu, Mohamad Mohty, Lionel Karlin, Andreea Rawlings, Christina Tekle, Sandrine Schwab, Marie-Laure Risse, Thomas Martin
Journal: Blood
Blood (2022) 140 (Supplement 1): 1820–1822.
https://doi.org/10.1182/blood-2022-159105
Published: 2022
Journal Articles

Updated Phase I/II Safety and Efficacy Results for Oral Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Relapsed/Refractory Immune Thrombocytopenia

David J. Kuter, Nikolay Tzvetkov, Merlin Efraim, Zane Kaplan, Jiří Mayer, Philip Choi, A.J. Gerard Jansen, Vickie McDonald, Ross Baker, Robert J. Bird, Mamta Garg, Jaromir Gumulec, Milan Kostal, Terry Gernsheimer, Waleed Ghanima, Olga Bandman, Puneet Arora, Regan Burns, Mengjie Yao, Ahmed Daak, Timothee Sourdille, Fareha Iqbal, Dolca Thomas, Ann Neale, Nichola Cooper
Journal: Blood
Blood (2021) 138 (Supplement 1): 14.
https://doi.org/10.1182/blood-2021-145128
Published: 2021
Journal Articles

Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Patients with Renal Impairment: Ikema Subgroup Analysis

Marcelo Capra, MD PhD, Thomas Martin, III, MD, Philippe Moreau, MD, Ross Baker, MBBS, FRACP, FRCPA, BSc, Ludek Pour, MD, Chang-Ki Min, MD PhD, Xavier Leleu, MD, Mohamad Mohty, MD PhD, Marta Reinoso Segura, Mehmet Turgut, MD, Richard Leblanc, MD FRCPC, Marie-Laure Risse, Laure Malinge, Sandrine Schwab, Meletios A Dimopoulos
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-136415
Published: 2020
Journal Articles

Chronic Lymphocytic Leukaemia Is Associated with a Broad Platelet-Function Defect Which Is Exacerbated By Ibrutinib and Acalabrutinib

Scott R McGregor, BPharm, Grace Gilmore, Elizabeth E. Gardiner, PhD, Sarah Hicks, Shilpa Rakesh, Jim Tiao, Ross Baker, MBBS, FRACP, FRCPA, BSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3756.
https://doi.org/10.1182/blood-2018-99-120234
Published: 2018
Journal Articles

Hormonal Regulation of the Anticoagulant Protein S.

Quintin Hughes, BSc(hons), Janelle Staton, PhD, Mark Watson, PhD, Jennet Harvey, MBBS, FRCPA, Ross Baker, MBBS, FRACP, FRCPA
Journal: Blood
Blood (2005) 106 (11): 1934.
https://doi.org/10.1182/blood.V106.11.1934.1934
Published: 2005